Immunome, Inc.
IMNM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$293 | -$107 | -$37 | -$25 |
| Dep. & Amort. | $2 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | -$7 | -$1 |
| Stock-Based Comp. | $16 | $6 | $5 | $3 |
| Change in WC | $15 | $12 | $2 | $3 |
| Other Non-Cash | $149 | $80 | $7 | $0 |
| Operating Cash Flow | -$111 | -$8 | -$29 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$1 | -$0 | -$0 |
| Net Acquisitions | $0 | $9 | $0 | $0 |
| Inv. Purchases | -$187 | -$39 | $0 | $0 |
| Inv. Sales/Matur. | $155 | $0 | $0 | $0 |
| Other Inv. Act. | -$46 | $0 | $0 | $0 |
| Investing Cash Flow | -$85 | -$30 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$0 |
| Stock Issued | $250 | $0 | $0 | $27 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$9 | $116 | $0 | $1 |
| Financing Cash Flow | $241 | $116 | $0 | $28 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $45 | $78 | -$29 | $9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $99 | $20 | $49 | $40 |
| End Cash | $143 | $99 | $20 | $49 |
| Free Cash Flow | -$164 | -$8 | -$29 | -$18 |